Host-Pathogen Interactions Influencing Zoonotic Spillover Potential and Transmission in Humans

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2023 Mar 30

PMID 36992308

Authors

Beatriz Escudero-Perez

Alexandre Lalande

Cyrille Mathieu

Philip Lawrence

Affiliations

Soon will be listed here.

Abstract

Emerging infectious diseases of zoonotic origin are an ever-increasing public health risk and economic burden. The factors that determine if and when an animal virus is able to spill over into the human population with sufficient success to achieve ongoing transmission in humans are complex and dynamic. We are currently unable to fully predict which pathogens may appear in humans, where and with what impact. In this review, we highlight current knowledge of the key host-pathogen interactions known to influence zoonotic spillover potential and transmission in humans, with a particular focus on two important human viruses of zoonotic origin, the Nipah virus and the Ebola virus. Namely, key factors determining spillover potential include cellular and tissue tropism, as well as the virulence and pathogenic characteristics of the pathogen and the capacity of the pathogen to adapt and evolve within a novel host environment. We also detail our emerging understanding of the importance of steric hindrance of host cell factors by viral proteins using a "flytrap"-type mechanism of protein amyloidogenesis that could be crucial in developing future antiviral therapies against emerging pathogens. Finally, we discuss strategies to prepare for and to reduce the frequency of zoonotic spillover occurrences in order to minimize the risk of new outbreaks.

Citing Articles

Human Riboviruses: A Comprehensive Study.

Mohan G, Choudhury A, Bhat J, Phartyal R, Lal R, Verma M J Mol Evol. 2024; 93(1):11-37.

PMID: 39739017 DOI: 10.1007/s00239-024-10221-9.

PANoptosis Regulation in Reservoir Hosts of Zoonotic Viruses.

Chandra A, Kesavardhana S Viruses. 2024; 16(11).

PMID: 39599847 PMC: 11599095. DOI: 10.3390/v16111733.

Zoonotic Paramyxoviruses: Evolution, Ecology, and Public Health Strategies in a Changing World.

Branda F, Pavia G, Ciccozzi A, Quirino A, Marascio N, Matera G Viruses. 2024; 16(11).

PMID: 39599803 PMC: 11599060. DOI: 10.3390/v16111688.

Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies.

Muthukutty P, MacDonald J, Yoo S Vaccines (Basel). 2024; 12(11).

PMID: 39591123 PMC: 11598775. DOI: 10.3390/vaccines12111220.

One Health Ethics and the Ethics of Zoonoses: A Silent Call for Global Action.

Rodriguez J Vet Sci. 2024; 11(9).

PMID: 39330773 PMC: 11435914. DOI: 10.3390/vetsci11090394.

References

Nuermberger E, Bishai W, Grosset J . Latent tuberculosis infection. Semin Respir Crit Care Med. 2005; 25(3):317-36. DOI: 10.1055/s-2004-829504. View

Pfeiffer J, Kirkegaard K . Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog. 2005; 1(2):e11. PMC: 1250929. DOI: 10.1371/journal.ppat.0010011. View

Habjan M, Pichlmair A, Elliott R, Overby A, Glatter T, Gstaiger M . NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol. 2009; 83(9):4365-75. PMC: 2668506. DOI: 10.1128/JVI.02148-08. View

Lawrence P, Escudero-Perez B . Henipavirus Immune Evasion and Pathogenesis Mechanisms: Lessons Learnt from Natural Infection and Animal Models. Viruses. 2022; 14(5). PMC: 9146692. DOI: 10.3390/v14050936. View

Habchi J, Tompa P, Longhi S, Uversky V . Introducing protein intrinsic disorder. Chem Rev. 2014; 114(13):6561-88. DOI: 10.1021/cr400514h. View

Le Sage V, Cinti A, McCarthy S, Amorim R, Rao S, Daino G . Ebola virus VP35 blocks stress granule assembly. Virology. 2016; 502:73-83. DOI: 10.1016/j.virol.2016.12.012. View

Ciencewicki J, Wang X, Marzec J, Serra M, Bell D, Polack F . A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection. FASEB J. 2014; 28(4):1947-56. PMC: 3963017. DOI: 10.1096/fj.13-239855. View

Lahti M, Lofgren J, Marttila R, Renko M, Klaavuniemi T, Haataja R . Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res. 2002; 51(6):696-9. DOI: 10.1203/00006450-200206000-00006. View

Helbig K, Carr J, Calvert J, Wati S, Clarke J, Eyre N . Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin. PLoS Negl Trop Dis. 2013; 7(4):e2178. PMC: 3630087. DOI: 10.1371/journal.pntd.0002178. View

10.

Schnorr J, Schneider-Schaulies S, Pavlovic J, Horisberger M, Ter Meulen V . MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol. 1993; 67(8):4760-8. PMC: 237862. DOI: 10.1128/JVI.67.8.4760-4768.1993. View

11.

Zhang Y, Zhao Y, Li N, Peng Y, Giannoulatou E, Jin R . Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun. 2013; 4:1418. PMC: 3562464. DOI: 10.1038/ncomms2433. View

12.

OBrien S, Dean M . In search of AIDS-resistance genes. Sci Am. 1997; 277(3):44-51. DOI: 10.1038/scientificamerican0997-44. View

13.

van Dorp L, Acman M, Richard D, Shaw L, Ford C, Ormond L . Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 2020; 83:104351. PMC: 7199730. DOI: 10.1016/j.meegid.2020.104351. View

14.

Pesce G, Gondelaud F, Ptchelkine D, Nilsson J, Bignon C, Cartalas J . Experimental Evidence of Intrinsic Disorder and Amyloid Formation by the W Proteins. Int J Mol Sci. 2022; 23(2). PMC: 8780864. DOI: 10.3390/ijms23020923. View

15.

Mehand M, Al-Shorbaji F, Millett P, Murgue B . The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antiviral Res. 2018; 159:63-67. PMC: 7113760. DOI: 10.1016/j.antiviral.2018.09.009. View

16.

Forton J, Rowlands K, Rockett K, Hanchard N, Herbert M, Kwiatkowski D . Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster. Thorax. 2009; 64(4):345-52. PMC: 3015100. DOI: 10.1136/thx.2008.102111. View

17.

Giefing-Kroll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B . How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015; 14(3):309-21. PMC: 4406660. DOI: 10.1111/acel.12326. View

18.

Kong W, Irie T, Yoshida A, Kawabata R, Kadoi T, Sakaguchi T . Inhibition of virus-like particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BST-2. Hiroshima J Med Sci. 2012; 61(3):59-67. View

19.

Upham N, Poelen J, Paul D, Groom Q, Simmons N, Vanhove M . Liberating host-virus knowledge from biological dark data. Lancet Planet Health. 2021; 5(10):e746-e750. PMC: 8457912. DOI: 10.1016/S2542-5196(21)00196-0. View

20.

Alhassan R, Nketiah-Amponsah E, Afaya A, Salia S, Abuosi A, Nutor J . Global Health Security Index not a proven surrogate for health systems capacity to respond to pandemics: The case of COVID-19. J Infect Public Health. 2022; 16(2):196-205. PMC: 9769026. DOI: 10.1016/j.jiph.2022.12.011. View